Descriptor English: | Antineoplastic Combined Chemotherapy Protocols | ||||||
Descriptor Spanish: |
Protocolos de Quimioterapia Combinada Antineoplásica
| ||||||
Descriptor Portuguese: | Protocolos de Quimioterapia Combinada Antineoplásica | ||||||
Descriptor French: | Protocoles de polychimiothérapie antinéoplasique | ||||||
Entry term(s): |
Agent, Combined Antineoplastic Agents, Combined Antineoplastic Anticancer Drug Combination Anticancer Drug Combinations Antineoplastic Agent, Combined Antineoplastic Agents, Combined Antineoplastic Chemotherapy Protocol Antineoplastic Chemotherapy Protocols Antineoplastic Combined Chemotherapy Regimens Antineoplastic Drug Combination Antineoplastic Drug Combinations Cancer Chemotherapy Protocol Cancer Chemotherapy Protocols Chemotherapy Protocol, Antineoplastic Chemotherapy Protocol, Cancer Chemotherapy Protocols, Antineoplastic Chemotherapy Protocols, Cancer Combinations, Antineoplastic Drug Combined Antineoplastic Agent Combined Antineoplastic Agents Drug Combination, Anticancer Drug Combination, Antineoplastic Drug Combinations, Anticancer Drug Combinations, Antineoplastic Protocol, Antineoplastic Chemotherapy Protocol, Cancer Chemotherapy Protocols, Antineoplastic Chemotherapy Protocols, Cancer Chemotherapy |
||||||
Tree number(s): |
E02.183.750.500 E02.319.077.500 E02.319.310.037 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000971 | ||||||
Scope note: | The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. |
||||||
Annotation: | coordinate IM with specific antineoplastic agents (IM or NIM) |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Previous Indexing: |
Drug Therapy, Combination (1974-1983) |
||||||
Public MeSH Note: | 2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001) |
||||||
History Note: | 2002(1984) |
||||||
DeCS ID: | 23947 | ||||||
Unique ID: | D000971 | ||||||
NLM Classification: | QZ 267 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1984/01/01 | ||||||
Date of Entry: | 1983/06/17 | ||||||
Revision Date: | 2015/06/23 |
-
-
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Therapeutics [E02]Therapeutics -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Therapeutics [E02]Therapeutics -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Therapeutics [E02]Therapeutics
|
Antineoplastic Combined Chemotherapy Protocols
- Preferred
Antineoplastic Chemotherapy Protocols
- Broader
Concept UI |
M0001485 |
Scope note | The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. |
Preferred term | Antineoplastic Combined Chemotherapy Protocols |
Entry term(s) |
Agent, Combined Antineoplastic Agents, Combined Antineoplastic Anticancer Drug Combination Anticancer Drug Combinations Antineoplastic Agent, Combined Antineoplastic Agents, Combined Antineoplastic Combined Chemotherapy Regimens Antineoplastic Drug Combination Antineoplastic Drug Combinations Combinations, Antineoplastic Drug Combined Antineoplastic Agent Combined Antineoplastic Agents Drug Combination, Anticancer Drug Combination, Antineoplastic Drug Combinations, Anticancer Drug Combinations, Antineoplastic |
Concept UI |
M0369990 |
Preferred term | Antineoplastic Chemotherapy Protocols |
Entry term(s) |
Antineoplastic Chemotherapy Protocol Cancer Chemotherapy Protocol Cancer Chemotherapy Protocols Chemotherapy Protocol, Antineoplastic Chemotherapy Protocol, Cancer Chemotherapy Protocols, Antineoplastic Chemotherapy Protocols, Cancer Protocol, Antineoplastic Chemotherapy Protocol, Cancer Chemotherapy Protocols, Antineoplastic Chemotherapy Protocols, Cancer Chemotherapy |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey